ArticleClinical ophthalmology (Auckland, N.Z.)2026

Real-World Outcomes of Switching to Faricimab in Treatment-Experienced and Resistant Neovascular Age-Related Macular Degeneration: A Single-Centre Retrospective Study.

Christopher Stewart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.